Search

Your search keyword '"D. Rezek"' showing total 20 results

Search Constraints

Start Over You searched for: Author "D. Rezek" Remove constraint Author: "D. Rezek" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
20 results on '"D. Rezek"'

Search Results

3. Quality of life, effectiveness and patient reported outcomes of antiemetic prophylaxis with NEPA within the German NIS AkyPRO: post-hoc analysis of patients receiving carboplatin-based chemotherapy

4. Nachhaltigkeit in der ästhetischen Mammachirurgie

5. Aktuelle Erkenntnisse zur Eigenfett Transplantation anhand der neuen Leitlinie 'Autologe Fetttransplantation'

6. Stellenwert der autologen Fetttransplantation in der ästhetischen Chirurgie des Mammakarzinoms

7. Evaluation des Therapiemanagements und der Therapieadhärenz bei postmenopausalen Patientinnen mit hormonrezeptorpositivem Mammakarzinom, die mit Letrozol behandelt werden – die EvaluateTM-Studie

8. Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study

10. Quality of Life Effects of an Oral Fixed Combination of Netupitant and Palonosetron in Chemotherapy-Induced Nausea and Vomiting Prevention: Real-World Evidence in Patients with Breast Cancer Receiving Anthracycline-Cyclophosphamide-Based Chemotherapy.

11. Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.

12. Autologous Lipotransfer - Daily Therapeutic Practice in Breast Cancer: An Intergroup Analysis Encompassing NOGGO, WSG, GBG, AWO Gyn and DGPRÄC.

13. Benchmarking of a checklist for the identification of familial risk for breast and ovarian cancers in a prospective cohort.

14. Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study.

15. Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study.

16. Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients.

17. Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

18. Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.

19. Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.

20. Paravalvular Regurgitation: Clinical Outcomes in Surgical and Percutaneous Treatments.

Catalog

Books, media, physical & digital resources